Back to Search
Start Over
Comparison of growth & function of endothelial progenitor cells cultured on deproteinized bovine bone modified with covalently bound fibronectin and bound vascular endothelial growth factor.
- Source :
-
Clinical oral implants research [Clin Oral Implants Res] 2017 May; Vol. 28 (5), pp. 543-550. Date of Electronic Publication: 2016 Mar 19. - Publication Year :
- 2017
-
Abstract
- Objectives: The objective of this study was to assess and compare the growth and function of Endothelial Progenitor Cells (EPCs) cultured on covalently bonded Vascular Endothelial Growth Factor (VEGF) and covalently bonded Fibronectin (FN) coating on deproteinized bovine bone (DBB) (test samples), compared to non-modified DBB blocks (control sample).<br />Materials and Methods: The test samples were prepared by plasma polymerization of allylamine onto DBB blocks. Group1 of test samples were prepared with VEGF coating (VEGF-DBB) where as the Group2 test samples were coated with FN (FN-DBB). Non-modified DBB blocks served as a Control. EPCs were isolated and cultivated from buffy coats of peripheral blood of healthy volunteers and cultivated in the different samples and examined at time intervals of 24 h, 3 days, and 7 days. Evaluation of growth by cell count and cell morphology was done using Confocal Laser Scanning Electron Microscopy; vitality and function of cells was assessed using MTT assay and RT-PCR and ELISA for eNOS and iNOS respectively.<br />Results: The results of the study show that both VEGF and FN could be successfully immobilized by plasma polymerization onto a complex, porous, three-dimensional structure of DBB. When comparing vital cell coverage, proliferation and function of EPCs, FN-DBB provided more positive values followed by VEGF-DBB as compared to DBB samples. eNOS level were significant higher in VEGF-DBB and FN-DBB when compared to DBB (P = 0.019 and P = 0.002). The difference between VEGF-DBB and FN-DBB was not significant.<br />Conclusions: Biomimetic coatings of Fibronectin may clinically relate to faster angiogenesis and earlier healing potential.<br /> (© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Subjects :
- Animals
Bone Substitutes pharmacology
Cattle
Cell Count
Cell Proliferation drug effects
Cells, Cultured
Endothelial Progenitor Cells drug effects
Enzyme-Linked Immunosorbent Assay
Fibronectins administration & dosage
Humans
Microscopy, Confocal
Nitric Oxide Synthase Type II metabolism
Nitric Oxide Synthase Type III metabolism
Real-Time Polymerase Chain Reaction
Vascular Endothelial Growth Factor A administration & dosage
Endothelial Progenitor Cells physiology
Fibronectins pharmacology
Vascular Endothelial Growth Factor A pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1600-0501
- Volume :
- 28
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Clinical oral implants research
- Publication Type :
- Academic Journal
- Accession number :
- 26992449
- Full Text :
- https://doi.org/10.1111/clr.12832